https://economist.com.na/23212/head...ll-take-over-of-langer-heinrich-uranium-mine/
“It is understood Paladin intends to fight the validity of the LH option through an arbitration process in Singapore, and that it has already received strong encouragement from many bondholders to take up the battle.”
It seems most posts on here since the ‘Ann: CNNC Purports to Exercise Langer Heinrich Call Option’ have essentially written-off Paladin.
I would like to see the CNNC supposed LH call option ruled invalid. There must be various arguments to support this. To start with, the initial announcement regarding the sale of 24% of LH to CNNC was made on 21 July 2016 – that is over 7 months ago now. CNNC failed to seemingly act or respond at any point during this time, which directly necessitated Pdn to make alternative plans i.e. the proposed restructuring of 10 Jan. 2017. I would like to see CNNCs failure over this 24% deal invalidate any right they consider they now have to buy 75% of LH.
As noted in the restructuring announcement of 10 Jan. 2017, all necessary regulatory approvals are required including Australia’s Foreign Investment Review Board (AFRB). How could the AFRB allow LH to be 100% sold to Chinese interests?
Surely, Pdn with legal support and assistance from Korda Mentha, can put up a strong legal challenge to this CNNC option.
It would be extremely disappointing if Paladin seemingly rolled over without a fight.
Any comments or feedback would be appreciated.
- Forums
- ASX - By Stock
- Singapore legal process
https://economist.com.na/23212/headlines/chinese-state-on-the-ver...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PDN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.88 |
Change
-2.800(28.9%) |
Mkt cap ! $2.057B |
Open | High | Low | Value | Volume |
$7.74 | $7.74 | $6.83 | $151.8M | 21.24M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 76475 | $6.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.89 | 4018 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 38081 | 6.880 |
1 | 985 | 6.870 |
2 | 1495 | 6.860 |
12 | 25638 | 6.850 |
7 | 49936 | 6.840 |
Price($) | Vol. | No. |
---|---|---|
6.890 | 4000 | 2 |
6.930 | 5772 | 1 |
6.940 | 5053 | 2 |
6.950 | 9000 | 1 |
6.970 | 500 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PDN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online